Industry
From U.S. (Toll Free) : +16467917070    |   UK : +442030260021     |    sales@businessmarketinsights.com

South and Central America Optical Coherence Tomography Angiography Equipment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Tabletop Type and Handheld Type) and End User (Hospitals, Clinics, and Others)

Report Code :  BMIRE00025110
No. of Pages :  98
Published Month :  Jun 2022
Category :  Life Sciences
$299 per month

Best Plan
  • All Reports in One Industry
  • All Reports Read Access
  • Subscription Duration : 12 Months
  • Monthly New Reports Added
  • $1200 Yearly Saving

The South and Central America optical coherence tomography angiography equipment market is expected to reach US$ 360.54 million by 2028 from US$ 223.74 million in 2021; It is estimated to grow at a CAGR of 6.4% from 2021 to 2028.

The growth of the market is due to the rising prevalence of eye-related disorders and rise in geriatric population. However, the lack of skilled professionals and technical challenges associated with the equipment restrict the market growth.

Eye-related conditions and disorders include diabetic retinopathy, glaucoma, age-related macular degeneration, ocular histoplasmosis, retinal vein occlusion, and retinal breaks and detachment. Diabetic retinopathy (DR) is caused due to high blood sugar levels that damage blood vessels of the retina or cause changes to them. These changes may include swelling, leakage, or closing, thus stopping the passage of the blood. In some people, abnormal new blood vessels grow on the surface of the retina. Such changes to the retina can hamper the vision of a person. According to the NCBI article, the number of adults with DR is expected to grow from ~103.12 million in 2020 to ~160.50 million by 2045 in the world. In addition, the DR is the most common diabetic eye disease and a leading cause of blindness among US adults. As per the National Eye Institute data, the number of Americans with DR is expected to double, from 7.7 million in 2010 to 14.6 million by 2050. With more than 150 million people estimated to be living with diabetes by 2040, the number of people suffering from diabetic retinopathy and vision impairment is also expected to rise in the future.

Glaucoma, ranked as the second-leading cause of blindness globally, damages the eye’s optic nerve. Among various causes of total blindness in adults, glaucoma caused 11.0% of blindness across the world in 2020, followed by diabetic retinopathy with 2.5% cases.

The optical coherence tomography (OCT) angiography helps in the evaluation of various ophthalmologic diseases, such as diabetic retinopathy, age-related macular degeneration (AMD), and retinal vascular occlusions, by providing a detailed view of the retinal vasculature that allows accurate delineation of abnormalities in diabetic eyes and vascular occlusions. It helps quantify vascular compromise depending on the severity of diabetic retinopathy. The OCT angiography can aid visibility in microaneurysms and retinal nonperfusion areas, enabling closer observation of each layer of retinal capillaries. It also evaluates the microvascular status and effectiveness of DR treatments. Hence, a rise in the prevalence of eye-related diseases boosts the adoption of OCT devices in hospitals and imaging centers, thereby driving the optical coherence tomography angiography equipment market growth.

South and Central America Optical Coherence Tomography Angiography Equipment Market Revenue and Forecast to 2028 (US$ Million)

 

SOUTH AND CENTRAL AMERICA OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SEGMENTATION

The South and Central America optical coherence tomography angiography equipment market, based on type, has been bifurcated into handheld type and tabletop type. The South and Central America optical coherence tomography angiography equipment market, based on end user is segmented into hospitals, clinics, and others. Geographically, the South and Central America optical coherence tomography angiography equipment market is divided into Brazil, Argentina and Rest of South and Central America.

Carl Zeiss AG; Canon Inc.; Michelson Diagnostics Ltd.; Alcon Inc.; and Topcon Corporation are among the leading companies operating in the South and Central America optical coherence tomography angiography equipment market.

  1. Carl Zeiss AG
  2. Alcon Inc.
  3. Topcon Corporation
  4. Canon Inc.
  5. Michelson Diagnostics Ltd.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America optical coherence tomography angiography equipment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South and Central America optical coherence tomography angiography equipment  market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.